Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05389462
Title A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | GBR | FRA | ESP


No variant requirements are available.